Bertelsmann India Investments led a $21m Series B round in CureBay Technologies.

Bertelsmann India Investments, an early growth stage investment firm, led a $21m Series B round in CureBay Technologies, a technology-enabled hybrid healthcare platform, with participation from British International Investment and Elevar Equity. The latest capital infusion will be utlised to strengthen CureBay’s in-house, proprietary technology stack, expansion across India, and hiring.